Tag Archives: RSLS

Blue Horseshoe Stocks: HOME Recap & More

Posted on by
Alibaba Group Holding Ltd. BABA – Options Idea

We’d like to start things off this morning by taking a look at BABA, which recently has formed a strong double-bottom setup on the chart. The stock is gapping up in premarket trading today, currently in the mid-$170′s and we’d like to formulate an extended term options idea to track over the next few weeks for an overdue recovery.

We’re going to zero in on the BABA 05/04 $180-187.50 Calls, which will give us plenty of time for the stock to realize the kind of gains that look very possible from a technical standpoint at this juncture.

At Home Group, Inc. HOME – Update

On the morning of March 23rd, we had selected a longer-term idea for the HOME options chain, and we wanted to take a look at the moves it has made in the three and a half weeks since that time.

Our target set of contracts was the HOME 04/20 $30 Calls, and with the stock surging to nearly $35 this week, those calls have been pushed well into the money and produced a heck of a gain opportunity. From the low shortly after our initial alert to a new high reach yesterday, we’ve seen a run from 1.31-5.50, which represents a chance at profits of up to 320%

Extended Watchlist:
ATRA, DQ, CHFS, RSLS, NVCN, HEAR

Blue Horseshoe Stocks: OREX Recap & More

Posted on by


Orexigen Therapeutics, Inc. OREX

On a day like yesterday, when the markets take an unexpected and brutal bath, it always helps to find a trend-bucker. Fortunately for us, all was not lost because we had included OREX on our watchlist in our premarket report.

Even as most other stocks wavered under the intensity of yesterdays bearish push, OREX ran from a daily low of .23 to a high of .39 for a 70% intraday run. It also closed with strength at .34, not too far below the area of a massive gap on the chart. We’ll definitely want to continue monitoring OREX, as even a partial filling of said gap would produce further gains of a significant magnitude.


_____

Bottom-Watch Plays

While we’re on the subject of bottom plays, we’re going to add both of the following to our working watchlist, as each one is extraordinarily oversold at the present time.

ReShape Life Sciences, Inc. RSLS
MoneyGram, International, Inc. MGI


Extended Watchlist:
AMPE, DFFN, CGEN, VATE, PLPL, CANB

Blue Horseshoe Stocks: RIOT, EGBN & More

Posted on by

Riot Blockchain, Inc. RIOT

We began tracking RIOT on November 2nd at a low of 6.33, mentioning it three times over the course of the next month. The stock saw a massive run ending last Monday hitting a high of 21.76, for a hefty move of 244%

It spent the rest of the week beginning to rebound off of the pullback to the $12-range which followed that huge spike, and is presently trading back in the $16-range. We’re going to want to continue to keep an eye on this blockchain related play, as almost anything even remotely tied to the white-hot sector has a chance to see further surges at any time if the price of BTC sees more new highs. As of this morning, one Bitcoin is worth just over $11,000USD.

Verizon, Inc. VZ

It has been a very solid run for VZ since we signaled a range of contracts to observe on the morning of November 17th, the VZ 01/19 $45-48 Calls.  We saw the stock trading at 44.62, and that was followed by sessions after session of new highs leading all the way through Friday, when it reached  51.55.

We wanted to provide yet another update on the total ranges of gains that were available in our options idea in the two weeks we’ve been tracking it now:

VZ 01/19 $45-48 Calls
$45 Calls – Range: 1.08 -6.40 – Max Gain: 493%
$46 Calls – Range: .59-5.48 – Max Gain: 829%
$47 Calls – Range: .39-4.56 – Max Gain: 1069%
$48 Calls – Range: .23-3.34 – Max Gain: 1352%


Eagle Bancorp, Inc. EGBN

We noticed an interesting set of events playing out with EGBN- the stock absolutely fell off a cliff last week, tumbling from nearly $70 on Wednesday, to the low $46-range on Friday. Apparently it was the result of a hyped up short seller report by Aurelius Value, an anonymous online firm that supports short-sellers. The company published a statement of its own calling the report “a deceptive and materially misleading piece“.

We tend to give credence to the actual company’s public statement rather than a group of shorts hiding behind a curtain somewhere. That’s why we’re going to place the EGBN 12/15 $50-60 Calls on watch in the days and weeks ahead, for what should be a forthcoming recovery in EGBN.

Extended Watchlist:
APRN, ASNA, CHFS, DPW, MDGS, PXS, UUUU, RSLS